SCHEMBL2804284

SCHEMBL2804284

CN(C)CCCCNc1ncc2c(n1)-c1ccccc1C(c1ccc(NC(=O)NC3CCCC3)cc1)C2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 5/20 0.44
MERTK Q12866 2/20 0.42
FGFR2 P21802 3/20 0.41
EGFR P00533 2/20 0.41
FGFR3 P22607 2/20 0.41
FGFR4 P22455 1/20 0.41
SELP P16109 1/20 0.39
TYRO3 Q06418 1/20 0.39
KDR P35968 2/20 0.37
EPHX1 P07099 4/20 0.37
CSF1R P07333 1/20 0.36
RAB9A P51151 4/20 0.36
MAPK14 Q16539 1/20 0.36
KIT P10721 1/20 0.36
FLT3 P36888 1/20 0.36
EPHX2 P34913 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPC1 O15118 3/20 0.35
CCNA2 P20248 1/20 0.35
CDK2 P24941 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2805430 0.99 FGFR1 (0.45) FGFR1MERTKFGFR2EGFRFGFR3
SCHEMBL2804914 0.99 FGFR1 (0.45) FGFR1MERTKFGFR2EGFRFGFR3
SCHEMBL2804236 0.91 FGFR1 (0.38) FGFR1MERTKFGFR2EGFRFGFR3
SCHEMBL2805009 0.89 FGFR1 (0.41) FGFR1MERTKFGFR2EGFRFGFR3
SCHEMBL2802460 0.89 FGFR1 (0.39) FGFR1MERTKFGFR2EGFRFGFR3
SCHEMBL2805255 0.87 FGFR1 (0.44) FGFR1MERTKFGFR2EGFRFGFR3
SCHEMBL16360137 0.87 FGFR1 (0.40) FGFR1MERTKFGFR2EGFRFGFR3
SCHEMBL2805358 0.86 FGFR1 (0.42) FGFR1MERTKFGFR2EGFRTYRO3
SCHEMBL2803447 0.86 FGFR1 (0.39) FGFR1MERTKFGFR2EGFRFGFR3
SCHEMBL2804758 0.85 MEN1 (0.39) FGFR1MERTKFGFR2EGFRFGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
WO-2010078421-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F] ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS NQO1, DPYD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 FGFR1 530/4885MERTK 3268/4885FGFR2 511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.